ADIPOCYTOKINES IN DEVELOPMENT INSULIN RESISTANCE IN OBESITY
DOI:
https://doi.org/10.21856/j-PEP.2010.3.17Keywords:
obesity, insulin resistance, adipose tissueAbstract
Adipose tissue is key regulator of energy balance and plays an active role in the accumulation of lipids, as well as the synthesis and secretion of a wide range of adipokines that could potentially be involved in pathogenetic events associated with obesityReferences
Grundy S. M. Obesity, metabolic syndrome, and cardiovascular disease [Text] / S. M. Grundy // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 2595– 2600.
Klaus S. Adipose tissue as a regulator of energy balance [Text] / S. Klaus // Curr Drug Targets. — 2004. — Vol. 5. — P. 241–250.
Trayhurn P. Adipokines: inflammation and the pleiotropic role of white adipose tissue [Text] / P. Trayhurn, I. S. Wood // Br. J. Nutr. — 2004. — Vol. 92. — P. 347–355.
Ahima R. S. Adipose tissue as an endocrine organ [Text] / R. S. Ahima, J. S. Flier // Trends Endocrinol. Metab. — 2000. — Vol. 11. — P. 327–332.
Hajer G. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases [Text] / G. Hajer, T.W. van Haeften, F. L. J. Visseren // European Heart Journal. — 2008. — Vol. 29. — P. 2959–2971.
Otto T. C. Adipose development: from stem cell to adipocyte [Text] / T. C. Otto, M. D. Lane // Crit. Rev. Biochem. Mol. Biol. — 2005. — Vol. 40. — P. 229–242.
Sharma A. M. Adipose tissue: a mediator of cardiovascular risk [Text] / A. M. Sharma // Int. J. Obes. Relat. Metab. Disord. — 2002. — Vol. 26 (Suppl 4). — P. S5–S7.
Adipose tissue as an endocrine organ: from theory to practice [Text] / M. H. Fonseca-Alaniz, J. Takada, M. I. Cardoso Alonso-Vale, F. B. Lima // J. Pediatr. (Rio J). — 2007. — Vol. 83 (5 Suppl.). — P. S192– 203.
Cinti S. The adipose organ: morphological perspectives of adipose tissues [Text] / S. Cinti // Proc. Nutr. Soc. — 2001. — Vol. 60. — P. 319–328.
Anghel S. I. Fat poetry: a kingdom for PPARγ [Text] / S. I. Anghel, W. Wahli // Research. — 2007. — Vol. 17. — P. 486–511.
Metabolism of lipids in human white Adipocyte [Text] / V. Large, O. Peroni, D. Letexier [et al.] // Diabetes Metab. — 2004. — Vol. 30. — P. 294– 309.
Unger R. H. Lipotoxicity of β-Cells in Obesity and in Other Causes of Fatty Acid Spillover [Text] / R. H. Unger, Yan-Ting Zhou //Diabetes. — 2001. — Vol. 50 (Suppl. 1). — P. S118–S121.
Kershaw E. E. Adipose tissue as an endocrine organ [Text] / E. E. Kershaw, J. S. Flier // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 2548– 2556.
Lazar M. A. The humoral side of insulin resistance [Text] / M. A. Lazar // Nat. Med. — 2006. — Vol. 12. — P. 43–44.
Relationship between adipocyte size and adipokine expression and secretion [Text] / T. Skurk, C. Alberti-Huber, C. Herder, H. Hauner // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92. — P. 1023– 1033.
Tsochatzis E. The evolving role of leptin and adiponectin in chronic liver diseases [Text] / E. Tsochatzis, G. V. Papatheodoridis, A. J. Archimandritis // Am. J. Gastroenterol. — 2006. — Vol. 101. — P. 2629–2640.
Trayhurn P. Adipocyte biology [Text] / P. Trayhurn // Obesity reviews. — 2007. — Vol. 8 (Suppl. 1). — P. 41–44.
Diamond F. The Endocrine Function of Adipose Tissue [Text] / F. Diamond // Growth, genetics and hormones. — 2002. — Vol. 18, issue 2. — P. 18–22.
Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation [Text] / C. E. Juge-Aubry, E. Somm, V. Giusti [et al.] // Diabetes. — 2003. — Vol. 52. — P. 1104–1110.
Relationship between serum adiponectin and leptin concentrations and body fat distribution [Text] / K. G. Park, K. S. Park, M. J. Kim [et al.] // Diabetes Res. Clin. Pract. — 2004. — Vol. 63. — P. 135– 142.
Redinger R. N. Obesity: pathophisiology and clinic features [Text] / R. N. Redinger //Gastroenterology and Hepatology. — 2007. — Vol. 3, Issue 1. — P. 856–863.
Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in nonobese and obese subjects [Text] / G. He, S. B. Pedersen, J. M. Bruun [et al.] // Horm Metab Res. — 2003. — Vol. 35. — P. 178–182.
Berg A. H. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [Text] / A. H. Berg // Nat.Med. — 2001. — Vol. 7. — P. 947–953.
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome [Text] / T. Kadowaki, T. Yamauchi, N. Kubota [et al.] // The Journal of Clinical Investigation. — 2006. — Vol. 116, Number 7. — P. 1784–1792.
Matrix Metalloproteinase Gene Delivery for Liver Fibrosis [Text] // Pharmaceutical Research. — 2007. — Vol. 25, No. 2. — P. 249–258.
Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse [Text] / H. Yoshiji, S. Kuriyama, J. Yoshii [et al.] // Hepatology. — 2002. — Vol. 36. — P. 850–860.
Fat storage in adipocytes requires inactivation of leptin’s paracrine activity: implications for treatment of human obesity [Text] / M. Y. Wang, L. Orci, M. Ravazzola [et al.] // Proc. Natl. Acad. Sci.USA. — 2005. — Vol. 102. — P. 18011–18016.
Frübeck G. Intracellular signalling pathways activated by leptin [Text] / G. Frübeck // Biochem J. — 2006. — Vol. 393. — P. 7–20.
Unger R. H. Hyperleptinemia: protecting the heart from lipid overload [Text] / R. H. Unger // Hypertension. — 2005. — Vol. 45. — P. 1031–1034.
Schwartz M. W. Central nervous system control of food intake [Text] / M.W. Schwartz, S. C. Woods, D. Jr. Porte [et al.] // Nature. — 2000. — Vol. 404 (6778). — P. 661–671.
Kaminski T. Leptin and long form of leptin receptor genes expression in the hypothalamus and pituitary during the luteal phase and early pregnancy in pigs [Text] / T. Kaminski, N. Smolinska, A. Gajewska [et al.] // J. Physiol Pharmacol. — 2006. — Vol. 57. — P. 95–108.
The role of SOCS-3 in leptin signaling and leptin resistance [Text] / C. Bjorbaek, K. El-Hashimi, J. D. Frantz [et al.] // J. Biol. Chem. — 1999. — Vol. 274. — P. 30059–30065.
A central role for JNK in obesity and insulin resistance [Text] / J. Hiroshumi, G. Tuncman, L. Chang [et al.] // Nature. — 2002. — Vol. 420. — P. 333– 336.
Niswender K. D. Insulin and its evolving partne with leptin in the hypothalami of energy homeostatis [Text] / K. D. Niswender, D. G. Baskin, M.W. Schwartz // TRENDS in Endocrinology and Metabolism. — 2004. — Vol. 15, No. 8. — P. 341–348.
Sethi J. K. The role of TNF alpha in adipocyte metabolism [Text] / J. K. Sethi, G. S. Hotamisligil // Semin. Cell Dev. Biol. — 1999. — Vol. 10. —P. 19–29.
Adipokines and insulin resistance [Text] / K. Rabe, V. Lehrke, K. G. Parhofer [et al.] // Mol. Med. —2008. — Vol. 14 (11–12). — P. 741–751.
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? [Text] / S. Engeli, P. Schling, K. Gorzelniak [et al.] // Int. J. Biochem. Cell Biol. — 2003. — Vol. 35. — P. 807–825.
Weight loss and the renin-angiotensin-aldosterone system [Text] / S. Engeli, J. Bohnke, K. Gorzelniak [et al.] // Hypertension. — 2005. — Vol. 45. — P. 356–362.
Sorhede W. M. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice [Text] / W. M. Sorhede, C. Magnusson, B. Ahren // Regul. Pept. — 2005. — Vol. 131. — P. 12–17.
Luk T. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity [Text] / T. Luk, Z. Malam, J. C. Marshall // Journal of Leukocyte Biology. — 2008. —Vol. 83. — P. 804–816.
The hormone resistin links obesity to diabetes [Text] / C. M. Steppan, S. T. Bailey, S. Bhat [et al.] // Nature. — 2001. — Vol. 409. — P. 307–312.
Increased resistin gene and protein expression in human abdominal adipose tissue [Text] / P. G. McTernan, C. L. McTernan, R. Chetty [et al.] // J. Clin. Endocrinol. Metab. — 2002. — Vol. 87. — P. 2407–2410.
Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation [Text] / A. Yao-Borengasser, N. Rasouli, V. Varma [et al.] // Diabetes. — 2006. —Vol. 55(10). — P. 2811–2818.
Moldes M. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue [Text] / M. Moldes, G. Beauregard, M. Faraj // European Journal of Endocrinology. — 2006. — Vol. 155, Issue 3. — P. 461–468.
Holst D. New factors in the regulation of adipose differentiation and metabolism [Text] / D. Holst, P. A. Grimaldi // Curr. Opin. Lipidol. — 2002. — Vol. 13. — P. 241–245.
Skurk T. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1 [Text] / T. Skurk, H. Hauner // Int. J. Obes. Relat. Metab. Disord. — 2004. — Vol. 28. — P. 1357–1364.
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk [Text] / I. Juhan-Vague, M. C. Alessi, A. Mavri [et al.] // J. Thromb. Haemost. — 2003. — Vol. 1. — P. 1575–1579.
Obesity is associated with macrophage accumulation in adipose tissue [Text] / S. P. Weisberg, D. McCann, M. Desai [et al.] // J. Clin. Invest. — 2003. — Vol. 112. — P. 1796–1808.
Recent advances in the relationship between obesity, inflammation, and insulin resistance [Text] / J. P. Bastard, M. Maachi, C. Lagathu [et al.] // Eur. Cytokine Netw. — 2006. — Vol. 17 (1). — P. 4–12.
Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone [Text] / G. B. Di Gregorio, A. Yao-Borengasser, N. Rasouli
[et al.] // Diabetes. — 2005. — Vol. 5. — P. 2305– 2310.
Gordon S. Monocyte and macrophage heterogeneity [Text] / S. Gordon, P. R. Taylor // Nat. Rev. Immunol. — 2005. — Vol. 5. — P.953–964.
Suganami T., Tanimoto-Koyama K., Nishida J. et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages [Text] // Arterioscler. Thromb. Vasc. Biol. — 2007. — Vol. 27. — P. 84–91.
Permana P. A., Menge C., Reaven P. D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance [Text] // Biochem. Biophys. Res. Commun. — 2006. — Vol. 341. — P. 507– 514.
Zhao T., Hou M., Xia M. et al. Globular adiponectin decreases leptin-induced tumor necrosis factor-α expression by murine macrophages: involvement of cAMP-PKA and MAPK pathways [Text] // Cell Immunol. — 2006. — Vol. 238. — P. 19–30.
Tilg H., Hotamisligil G. S. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance [Text] // Gastroenterology. — 2006. — Vol. 131. — P. 934–945.
Emanuelli B., Glondu M., Filloux C. et al. The potential role of SOCS-3 in the interleukin-1β-induced desensitization of insulin signaling in pancreatic β-cells [Text] // Diabetes. — 2004. — Vol. 53 (Suppl. 3). — P. S97–S103.
Hotamisligil G. S., Peraldi P., Budavari A. et al. IRSv1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha andobesityinduced insulin resistance [Text] // Science. — 1996. — Vol. 271. — P. 665–678.
Braissant O.., Foufelle F., Scotto C. et al. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, - β, and -γ in the adult rat [Text] // Endocrinology. — 1996. — 137, № 1. — P. 354–366.
Vidal-Puig A., Jimenez-Linan M., Lowell B. B. et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents [Text] // J. Clin. Invest. — 1996. — Vol. 97. — P. 2553–2561.
Imai T., Takakuwwa R., Marchand S., et al. PPARγ is required in mature white and brown adipocytes for their survival in the mouse [Text] // Proceeding of the National Academy of Sciences of the United States of America. — 2004. — 101. — P. 4543–4547.
Kubota N., Terauchi Y., Miki H. et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance [Text] // Molecular Cell. — 1999. — Vol. 4, № 4. — P. 597–609.
Odegaard J. I. Macrophagespecific PPARγ controls alternative activation and improves insulin resistance [Text] / J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth [et al.] // Nature. — 2007. — Vol. 447, № 7148. — P. 1116–1120.
Hausman G. J. Search for the preadipocyte progenitor cell [Text] / G. J. Hausman, D. B. Hausman // J. Clin. Invest. — 2006. — Vol. 116. — P. 3103– 3106.
Maeda N. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adiposederived protein [Text] / N. Maeda, M. Takahashi, T. Funahashi [et al.] // Diabetes. — 2001. — Vol. 50. — P. 2094–2099.
Nawrocki A. R. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists [Text] / A. R. Nawrocki, M.W. Rajala [et al.] // J. Biol. Chem. — 2006. — Vol. 281. —
P. 2654–2660.
Yu J. G. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects [Text] / J. G. Yu., S. Javorschi, A. L. Hevener. [et al.] // Diabetes. — 2002. — Vol. 51. — P. 2968–2974.
Burgermeister E. A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro [Text] / E. Burgermeister, A. Schnoebelen, A. Flament [et al.] // Molecular Endocrinology. — 2006. — Vol. 20, No. 4. — P. 809–830.
Fang Zhang. Selective Modulators of PPAR-γ Activity: Molecular Aspects Related to Obesity and Side-Effects [Text] / Fang Zhang, B. E. Lavan, M. Francine // PPAR Research. — 2007. — Vol. 2007. — Article ID 32696. — 7 p.